Maspin is a deoxycholate-inducible, anti-apoptotic stress-response protein differentially expressed during colon carcinogenesis

Clinical and Experimental Gastroenterology

Volumn 4, Issue 1, 2011, Pages 239-243

  Payne, Claire M ^a,b   Holubec, Hana ^a   Crowley Skillicorn, Cheray ^a   Nguyen, Huy ^a   Bernstein, Harris ^a   Wilcox, George ^c   Bernstein, Carol ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Biomedical Diagnostics and research inc   (United States)

^c Tucson Med Center   (United States)

Author keywords

Anti apoptotic; Bile acid inducible; Colon cancer; Immunohistochemistry; Maspin

Indexed keywords

DEOXYCHOLIC ACID; MASPIN;

ARTICLE; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; COLON MUCOSA; COLON POLYP; COLON POLYPOSIS; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 80955124010     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S24093     Document Type: Article

References (92)

1. Bernstein H, Bernstein C, Payne CM, Garewal H. Recent molecular evidence illuminates the decades-long debate on the role of dietary fat in colon carcinogenesis. J Cancer Integr Med. 2004;2: 107-109.
2. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res. 2005;589(1):47-65.
3. Bernstein C, Payne CM, Dvorak, K, Bernstein H. Role of bile acids in gastrointestinal carcinogenesis. US Gastroenterol Hepatol Rev. 2008; 4:68-72.
4. Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 2009;15(27):3329-3340.
5. Crowley-Weber CL, Payne CM, Gleason-Guzman M, et al. Development and molecular characterization of colon cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis. 2002;23(12):2063-2080.
6. McCormick F. Cancer: survival pathways meet their end. Nature. 2004;428(6980):267-269.
7. Wendel HG, De Stanchina E, Fridman JS, et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature. 2004;428(6980):332-337.
8. Payne CM, Bernstein H, Bernstein C, Garewal H. The role of apop-tosis in biology and pathology: Resistance to apoptosis in colon carcinogenesis. Ultrastruct Pathol. 1995;19(4):221-248.
9. Bernstein C, Bernstein H, Garewal H, et al. A bile acid-induced apop-tosis assay for colon cancer risk, and associated quality control studies. Cancer Res. 1999;59(10):2353-2357.
10. Payne CM, Bernstein C, Dvorak K, Bernstein H. Hydrophobic bile acids, genomic instability, Darwinian selection and colon carcinogenesis. Clin Exp Gastroenterol. 2008;1:19-47.
11. Payne CM, Crowley-Skillicorn C, Bernstein C, Holubec H, Bernstein H. Molecular and cellular pathways associated with chromosome 1p deletion during colon carcinogenesis. Clin Exp Gastroenterol. 2011; 4:75-119.
12. Sheng S, Pemberton PA, Sager R. Production, purifcation, and characterization of recombinant maspin proteins. J Biol Chem. 1994;269(49): 30988-30993.
13. Schneider SS, Schick C, Fish KE, et al. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci U S A. 1995; 92(8):3147-3151.
14. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 1994; 263(5146):526-529.
15. Seftor R, Seftor EA, Sheng S, Pemberton PA, Sager R, Hendrix MJC. Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res. 1998;58(24):5681-5685.
16. Pemberton PA, Wong DT, Gibson HL, et al. The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin. J Biol Chem. 1995;270(26):15832-15837.
17. Narayan M, Twining S. Focus on molecules: maspin. Exp Eye Res. 2010;90(1):2-3.
18. Liu J, Yin S, Reddy N, Spencer C, Sheng S. Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res. 2004;64(5):1703-1711.
19. Li Z, Shi H Y, Zhang M. Targeted expression of maspin in tumor vas-culatures induces endothelial cell apoptosis. Oncogene. 2005;24(12): 2008-2019.
20. Latha K, Zhang W, Cella N, Shi H Y, Zhang M. Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol Cell Biol. 2005;25(5):1737-1748.
21. Zhang W, Shi HY, Zhang M. Maspin overexpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins. BMC Cancer. 2005;5:50.
22. Schaefer JS, Zhang M. Targeting maspin in endothelial cells to induce cell apoptosis. Expert Opin Ther Targets. 2006;10(3):401-408.
23. Li X, Chen D, Yin S, et al. Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells. J Cell Physiol. 2007;212(2): 298-306.
24. Toillon RA, Lagadec C, Page A, et al. Proteomics demonstration that normal breast epithelial cells can induce apoptosis of breast cancer cells through insulin-like growth factor-binding protein-3 and maspin. Mol Cell Proteomics. 2007;6(7):1239-1247.
25. McKenzie S, Sakamoto S, Kyprianou N. Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT. Oncogene. 2008;27(57):7171-7179.
26. Bettstetter M, Woenckhaus M, Wild PJ, et al. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer. J Pathol. 2005;205(5):606-614.
27. Boltze C. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis. Pathol Res Pract. 2005;200(11-12): 783-790.
28. Cao D, Wilentz RE, Abbruzzese JL, Ho L, Maitra A. Aberrant expression of maspin in idiopathic infammatory bowel disease is associated with disease activity and neoplastic transformation. Int J Gastrointest Cancer. 2005;36(1):39-46.
29. Zheng H, Tsuneyama K, Cheng C, et al. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors. Anticancer Res. 2007;27(1A):259-265.
30. Markl B, Arnholdt HM, Jahnig H, et al. Shift from cytoplasmic to nuclear maspin expression correlates with shorter overall survival in node-negative colorectal cancer. Hum Pathol. 2010;41(7):1024-1033.
31. Pasz-Walczak G, Salagacka A, Potemski P, Balcerczak E, Korder R, Mirowski M. Maspin and Nm23-H1 expression in colorectal cancer. Neoplasma. 2010;57(2):95-101.
32. Payne CM, Crowley-Weber CL, Dvorak K, et al. Mitochondrial perturbation attenuates bile acid-induced cytotoxicity. Cell Biol Toxicol. 2005;21(5-6):215-231.
33. Payne CM, Crowley-Skillicorn C, Holubec H, et al. Deoxycholate, an endogenous cytotoxin/genotoxin, induces the autophagic stress-survival pathway: Implications for colon carcinogenesis. J Toxicol. 2009:1-14; article ID 785907; doi:10.1155/2009/785907.
34. Payne CM, Crowley-Skillicorn C, Bernstein C, Holubec H, Moyer M P, Bernstein H. Hydrophobic bile acid-induced micronuclei formation, mitotic perturbations and decreases in spindle checkpoint proteins: Relevance to genomic instability in colon carcinogenesis. Nutr Cancer 2010;62(6):825-840.
35. Yan Q, Briehl M, Crowley CL, Payne CM, Bernstein H, Bernstein C. The NAD+ precursors, nicotinic acid and nicotinamide upregulate glyceraldehyde-3-phosphate dehydrogenase and glucose-6-phosphate dehydrogenase mRNA in Jurkat cells. Biochem Biophys Res Commun. 1999;255(1):133-136.
36. Qi L, Sit KH. Housekeeping genes commanded to commit suicide in CpG-cleavage commitment upstream of Bcl-2 inhibition in caspase-dependent and independent pathways. Mol Cell Biol Res Comm. 2000; 3(5):319-327.
37. Dittmer A, Dittmer J. Beta-actin is not a reliable loading control in Western blot analysis. Electrophoresis. 2006;27(14):2844-2845.
38. Kuzelova K, Pluskalova M, Grebenova D, Pavlaskova K, Halada P, Hrkal Z. Changes in cell adhesivity and cytoskeleton-related proteins during imatinib-induced apoptosis of leukemic JURL-MK1 cells. J Cell Biochem. 2010;111(6):1413-1425.
39. Bernstein H, Holubec H, Warneke JA, et al. Patchy field defects of apoptosis resistance and dedifferentiation in fat mucosa of colon resections from colon cancer patients. Ann Surg Oncol. 2002;9(5):505-517.
40. Payne CM, Holubec H, Bernstein C, et al. Crypt-restricted loss and decreased protein expression of cytochromec oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk. Cancer Epidemiol Biomarkers Prevent. 2005;14(9):2066-2075.
41. Bernstein H, Prasad A, Holubec H, et al. Reduced Pms2 in non-neoplastic fat mucosa from patients with colon cancer correlates with reduced apoptosis competence. Appl Immunohistochem Mol Morphol. 2006;14(2):166-172.
42. Bernstein C, Facista A, Nguyen H, et al. Cancer and age related colonic crypt defciencies in cytochrome c oxidase I. World J Gastrointest Oncol. 2010;2(12):429-442.
43. Holubec H, Payne CM, Bernstein H, et al. Assessment of apoptosis by immunohistochemical markers compared to cellular morphology in ex vivo-stressed colonic mucosa. J Histochem Cytochem. 2005; 53(2):229-235.
44. Bernstein H, Payne CM, Kunke K, et al. A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis. 2004;25(5): 681-692.
45. Payne CM, Waltmire CN, Crowley C, et al. Caspase-6 mediated cleavage of guanylate cyclase α1 during deoxycholate-induced apoptosis: Protective role of the nitric oxide signaling module. Cell Biol Toxicol. 2003;19(6):373-392.
46. Dall'Agnol M, Bernstein C, Bernstein H, Garewal H, Payne CM. Identifcation of S- nitrosylated proteins after chronic exposure of colonic epithelial cells to deoxycholate. Proteomics. 2006;6(5):1654-1662.
47. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappaB transcription factor and HIV-1. EMBO J. 1991;10(8):2247-2258.
48. Turpaev KT. Reactive oxygen species and regulation of gene expression. Biochem (Mosc). 2002;67(3):281-292.
49. Olofsson BA, Kelly CM, Kim J, Hornsby SM, Azizkhan-Clifford J. Phosphorylation of SP1 in response to DNA damage by ataxia telangiectasia-mutated kinase. Mol Cancer Res. 2007;5(12):1319-1330.
50. Iwahori S, Yasui Y, Kudoh A, et al. Identifcation of phosphorylation sites on transcription factor Sp1 in response to DNA damage and its accumulation at damaged sites. Cell Signal. 2008;20(10):1795-1803.
51. Zou Z, Gao C, Nagaich AK, et al. p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem. 2000;275(9): 6051-6054.
52. Talos F, Moll UM. Role of the p53 family in stabilizing the genome and preventing polyploidization. Adv Exp Med Biol. 2010;676:73-91.
53. Yoshida K, Miki. The cell death machinery governed by the p53 tumor suppressor in response to DNA damage. Cancer Sci. 2010; 101(4): 831-835.
54. Maekawa T, Sano Y, Shinagawa T, et al. ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors. Oncogene. 2008;27(8):1045-1054.
55. Bowen C, Gelmann E P. NKX3.1 activates cellular response to DNA damage. Cancer Res. 2010;70(8):3089-3097.
56. Khalkhali-Ellis Z. Maspin: the new frontier. Clin Cancer Res. 2006;12(24):7279-7283.
57. Gao F, Shi HY, Daughty C, Cella N, Zhang M. Maspin plays an essential role in early embryonic development. Development. 2004;131(7):1479-1489.
58. Nelson DA, Tan T-T, Rabson AB, Anderson D, Degenhardt K, White E. Hypoxia and defective apoptosis drive genomic instability and tumori-genesis. Genes Dev. 2004;18(17):2095-2107.
59. Mendez O, Fernandez Y, Peinado MA, Moreno V, Sierra A. Anti-apoptotic proteins induce non-random genetic alterations that result in selecting breast cancer metastatic cells. Clin Exp Metastasis. 2005; 22(4):297-307.
60. Law RH, Irving JA, Buckle AM, et al. The high resolution crystal structure of the human tumor suppressor maspin reveals a novel conforma-tional switch in the G-helix. J Biol Chem. 2005;280:22356-22364.
61. Nawata S, Shi HY, Sugino N, Zhang M. Evidence of post-translational modifcation of the tumor suppressor maspin under oxidative stress. Int J Mol Med. 2011;27(2):249-254.
62. Cumming RC, Andon NL, Haynes PA, Park M, Fischer WH, Schubert D. Protein disulfde bond formation in the cytoplasm during oxidative stress. J Biol Chem. 2004;279(21):21749-21758.
63. Sheng S. Maspin and the order of signaling. Cancer Biol Ther. 2003; 2(4):404-405.
64. Nam E, Park C. Maspin suppresses survival of lung cancer cells through modulation of Akt pathway. Cancer Res Treat. 2010;42(1):42-47.
65. Pop C, Salvesen GS. Human caspases: Activation, specificity, and regulation. J Biol Chem. 2009;284(33):21777-21781.
66. Yin S, Li X, Meng Y, et al. Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-tranferase. J Biol Chem. 2005;280(41):34985-34996.
67. Nobuoka A, Takayama T, Miyanishi K, et al. Glutathione-S-transferase P1-1 protects aberrant crypt foci from apoptosis induced by deoxycholic acid. Gastroenterol. 2004;127(2):428-443.
68. Ravagnan L, Gurbuxani S, Susin SA, et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol. 2001;3(9):839-843.
69. Gurbuxani S, Schmitt E, Cande C, et al. Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene. 2003;22(43):6669-6678.
70. Matsumori Y, Hong SM, Aoyama K, et al. HSP70 overexpression sequesters AIF and reduces neonatal hypoxic/ischemic brain injury. J Cereb Blood Flow Metab. 2005;25(7):899-910.
71. Lui JC, Kong SK. Heat shock protein 70 inhibits the nuclear import of apoptosis-inducing factor to avoid DNA fragmentation in TF-1 cells during erythropoiesis. FEBS Lett. 2007;581(1):109-117.
72. Zhu Q, Xu YM, Wang L F, et al. Heat shock protein 70 silencing enhances apoptosis inducing factor-mediated cell death in hepatocel-lular carcinoma HepG2 cells. Cancer Biol Ther. 2009;8(9):792-798.
73. Choudhury S, Bae, Ke Q, Lee JY, Kim J, Kang PM. Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/ reperfusion. Basic Res Cardiol. 2011;106(3):397-407.
74. Ye H, Cande C, Stephanou NC, et al. DNA binding is required for the apoptogenic actin of apoptosis inducing factor. Nat Struct Biol. 2002;9(9):680-684.
75. Vahsen N, Cande C, Dupaigne P, et al. Physical interaction of apoptosis-inducing factor with DNA and RNA. Oncogene. 2006;25(12): 1763-1774.
76. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 1999;397(6718):441-446.
77. Modjtahedi N, Giordanetto F, Madeo F, Kroemer G. Apoptosis-inducing factor: vital and lethal. Trends Cell Biol. 2006;16(5):264-272.
78. Bernstein C, Bernstein H, Payne CM, Dvorak K, Garewal H. Field defects in progression to gastrointestinal tract cancers. Cancer Lett. 2009;260(1-2):1-10.
79. Nguyen H, Loustaunau C, Facista A, et al. Defcient Pms2, ERCC1, Ku86, CcOI in feld defects during progression to colon cancer. J Vis Exp. July 28, 2010;(41). Pii: 1931. doi: 10.3791/1931.
80. Bernstein C, Holubec H, Bhattacharyya AK, et al. Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol. 2011;85(8): 863-871.
81. Payne CM, Holubec H, Bhattacharyya AK, Bernstein C, Bernstein H. Exposure of mouse colon to dietary bile acid supplement induces sessile adenomas. Infamm Bowel Dis. 2009;16(5):729-730.
82. Blandamura S, D'Alessandro E, Guzzardo V, et al. Maspin expression in adenocarcinomas of the ampulla of Vater: relation with clinicopathological parameters and apoptosis. Anticancer Res. 2007;27(2):1059-1066.
83. Rana SS, Bhasin DK, Singh K. Ampulla of Vater as seen on capsule endoscopy. Gastrointest Endoscopy. 2008;68(3):613.
84. Washo-Stultz D, Hoglen N, Bernstein H, Bernstein C, Payne CM. Role of nitric oxide and peroxynitrite in bile salt-induced apoptosis: relevance to colon carcinogenesis. Nutr Cancer. 1999;35(2):180-188.
85. Washo-Stultz D, Crowley-Weber CL, Dvorakova K, et al. Role of mitochondrial complexes I and II, reactive oxygen species and arachi-donic acid metabolism in deoxycholate-induced apoptosis. Cancer Lett. 2002;177(2):129-144.
86. Bernstein H, Holubec H, Bernstein C, et al. Deoxycholate-induced colitis is markedly attenuated in Nos2 knock-out mice in association with modulation of gene expression profles. Dig Dis Sci. 2007; 52(3):628-642.
87. Payne CM, Weber C, Crowley-Skillicorn C, et al. Deoxycholate induces mitochondrial oxidative stress and activates NF-κB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis. 2007; 28(1):215-222.
88. Payne CM, Crowley C, Washo-Stultz D, et al. The stress-response proteins poly(ADP-ribose) polymerase and NF-κB protect against bile salt-induced apoptosis. Cell Death Diff. 1998;5(7):623-636.
89. Bernstein H, Payne C, Bernstein C, Beard S, Schneider J, Crowley C. Activation of the promoters of genes associated with DNA damage, oxidative stress, ER stress and protein malfolding by the bile salt, deoxycholate. Toxicol Lett. 1999;108(1):37-46.
90. Glinghammar B, Inoue H, Rafter JJ. Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-κB and AP-1. Carcinogenesis. 2002;23(5):839-845.
91. Terzic J, Grivennikov S, Karin E, Karin M. Infammation and colon cancer. Gastroenterol. 2010;138(6):2101-2114.
92. Kawanishi S, Hiraku Y. Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to infammation. Antioxidants Redox Signal. 2006;8(5-6):1047-1058.